HarrisMartin's Cyber Monday Event is Going on NOW! All Annual Subscriptions are 30% off; 6-Month Subscriptions are 10% off. Discount already removed from prices online. Don't wait - this discount is available for one day only - SUBSCRIBE HERE!
Get ready for the next wave of pharmaceutical and medical device litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
Download a publication order form here or subscribe here.
Drugs & Medical Devices - Issue: 60
Texas Jury Awards $19.4 Million to Plaintiffs in Remicade Injury Suit
Zyprexa Judge Urges Congress to Extend Class Action Rules to MDLs
Court: Defendant Can't Yet Rely on Unavoidably Unsafe Products Doctrine
Judge Awards Summary Judgment to Wyeth on Preemption Argument
Eli Lilly: Lack of Epidemiology, Causation Evidence 'Frustrating' Zyprexa MDL
HRT Plaintiff's Ovarian Cancer Risk Not Foreseeable, Wyeth Contends
Journal Top Ten -- COLUMNS-Drugs & Supplements -- December 2006
Judge Rejects Novartis Preemption Argument in Pharmaceutical Injury Case
